News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Calcineurin Inhibitor plus Eltrombopag in reducing transfusion requirements
Yale Cancer Center/X
Dec 11, 2024, 00:01

Calcineurin Inhibitor plus Eltrombopag in reducing transfusion requirements

Yale Cancer Center shared a post on X:

“Jessica M. Stempel and Dr. Nikolai Podoltsev share research demonstrating that Calcineurin Inhibitor plus Eltrombopag is effective in reducing transfusion requirements for patients with acquired Aplastic Anemia.”

Calcineurin Inhibitor

More posts featuring Yale Cancer Center.

acquired Aplastic Anemia anemia Calcineurin Inhibitor cancer Eltrombopag Jessica M. Stempel Nikolai Podoltsev OncoDaily Oncology patients Yale Cancer Center
Special Coverage
Science
Sep 3, 2025, 08:11
Sanam Loghavi: Cytomolecular Drivers of Relapse After Frontline FLT3 Inhibitor Therapy in FLT3-Mutated AML
Voices
Sep 3, 2025, 08:06
Douglas Flora: What it's Like to Be a Cancer Patient - Leaves, Branches, and Roots
Voices
Sep 3, 2025, 08:01
No Child Left Behind: Prioritizing Childhood Cancer in the Next EU Budget - AIEOP
Voices
Sep 3, 2025, 07:58
Anh Lam: Join us in Chicago for ASCO Quality Care Symposium
Insight
Sep 3, 2025, 07:55
Oncology Updates: August Edition from BG Lab
Science
Sep 3, 2025, 07:49
Alessandro Di Federico: Not All Oncogenes Are the Same
Career Updates
Sep 3, 2025, 07:48
Matthew Kurian: Registration is Open for Implications of HER2 Testing in Cancer Management Session
Voices
Sep 3, 2025, 07:37
Tyler Seibert: Rare but Tragic Outcomes After Radiation for Pelvic Cancers
Societies
Sep 3, 2025, 07:28
Free Childcare for Congress Delegates With Children Aged 1–12 - ESGO
Voices
Sep 3, 2025, 07:14
Eric Whitman: Register for Virtual Post-ASCO Conference on September 20
Science
Sep 3, 2025, 07:05
Jean-Jacques Kiladjian: Pemigatinib for Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
Science
Sep 3, 2025, 07:03
Bishal Gyawali: We Had Quite a Productive Month in August at BG Lab